- World rank, all time
- #16,305 of 42,892
- Rank in Spain
- #402 of 927
- Research works
- 754 ▼ 84% vs 2013–17
- Citations
- 19k 25.0 per fractional work
- Top-10% rate
- 5.1% record average 16.5%
- Open access
- 23% world 28%
What is Hospital Xeral Calde known for in research?
The fields where it stands highest, over all time, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works |
|---|---|---|---|---|
| MedicineField | #7,824 of 17,978 | 13.1% | 589 | |
| Health SciencesDomain | #10,238 of 20,462 | 12.9% | 620 |
Each strip is that field’s whole ranked pool, with the notch where Hospital Xeral Calde sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Dentistry, 5.8×. Every wedge is a field page.
Who are the top researchers at Hospital Xeral Calde?
Ranked on the composite score, Carlos Garcı́a-Porrúa and Nogueira March Jl lead among researchers whose main affiliation is Hospital Xeral Calde.
- 1 Carlos Garcı́a-Porrúa Spain · #272,546 worldwide 115 citations · 36 works
- 2 Nogueira March Jl Spain · #1,412,207 worldwide 1 citations · 16 works
Which keywords describe research at Hospital Xeral Calde?
By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Diagnosis, Treatment, Inflammation, Autoantibodies, Rituximab, Management and Chemotherapy.
- Diagnostic Imaging
- Joint Inflammation
- Systemic Lupus Erythematosus
- VEXAS Syndrome
- Molecular Characterization
- Rheumatoid Arthritis
- Endothelial Dysfunction
- Antiretroviral Therapy
- Immunosuppressive Therapy
- Clinical Management
- Cytokines
- Cardiovascular Risk
- Immunotherapy
- Vasculitides
- ANCA-associated
- Genetic Mutations
- Chemotherapy
- Rituximab
- Treatment
- Inflammation
- Epidemiology
- Diagnosis
- Autoantibodies
- Management
- Quality of Life
- Clinical Practice Guidelines
- Pathogenesis
- Surgical Management
- Risk Factors
- Complications
- Prognostic Factors
- Guidelines
- Surgery
- Clinical Features
- Radiotherapy
- Somatic Mutations
- Relapsing Polychondritis
- Biological Therapy
- Disease-Modifying Antirheumatic Drugs
- Prenatal Diagnosis
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology112▲ 3.7×102 topics
- Inflammation56▲ 3.2×62 topics
- Diagnosis56▲ 7.3×37 topics
- Treatment56▲ 5.7×40 topics
- Autoantibodies36▲ 20×8 topics
- Rituximab31▲ 26×4 topics
- Management30▲ 5.2×26 topics
- Chemotherapy29▲ 5.5×23 topics
- Quality of Life28▲ 2.8×32 topics
- Genetic Mutations26▲ 6.7×20 topics
- Clinical Practice Guidelines26▲ 6.1×13 topics
- ANCA-associated24▲ 134×1 topic
- Pathogenesis24▲ 5.6×21 topics
- Vasculitides24▲ 134×1 topic
- Surgical Management23▲ 6.8×17 topics
- Immunotherapy22▲ 4.6×17 topics
- Risk Factors22▲ 2.8×19 topics
- Cardiovascular Risk19▲ 7.3×7 topics
- Complications17▲ 4.5×13 topics
- Cytokines17▲ 8.4×6 topics
- Prognostic Factors17▲ 4.9×14 topics
- Clinical Management16▲ 10×8 topics
- Guidelines16▲ 4.3×12 topics
- Immunosuppressive Therapy16▲ 11×8 topics
- Surgery15▲ 6.2×9 topics
- Antiretroviral Therapy15▲ 8.6×6 topics
- Clinical Features14▲ 52×3 topics
- Endothelial Dysfunction14▲ 6.4×8 topics
- Radiotherapy14▲ 5.0×12 topics
- Rheumatoid Arthritis13▲ 17×4 topics
- Somatic Mutations13▲ 27×2 topics
- Molecular Characterization13▲ 9.2×6 topics
- Relapsing Polychondritis13▲ 185×1 topic
- VEXAS Syndrome13▲ 185×1 topic
- Biological Therapy12▲ 30×2 topics
- Systemic Lupus Erythematosus12▲ 29×2 topics
- Disease-Modifying Antirheumatic Drugs12▲ 32×1 topic
- Joint Inflammation12▲ 32×1 topic
- Prenatal Diagnosis11▲ 7.9×7 topics
- Diagnostic Imaging10▲ 11×4 topics
Which research topics does Hospital Xeral Calde publish most on?
By volume in 2022–2025: Neurogenetic and Muscular Disorders Research, Spinal Dysraphism and Malformations, Hip disorders and treatments and Electric Vehicles and Infrastructure.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Neurogenetic and Muscular Disorders Research Genetics 0 works
- 2 Spinal Dysraphism and Malformations Public Health, Environmental and Occupational Health 0 works
- 3 Hip disorders and treatments Surgery 0 works
- 4 Electric Vehicles and Infrastructure Electrical and Electronic Engineering 0 works
- 5 Microgrid Control and Optimization Control and Systems Engineering 0 works
- 6 Power Quality and Harmonics Electrical and Electronic Engineering 0 works
- 7 Artificial Intelligence in Healthcare and Education Health Informatics 0 works
- 8 Autopsy Techniques and Outcomes Radiology, Nuclear Medicine and Imaging 0 works
- 9 Medical Malpractice and Liability Issues Pharmacy 0 works
- 10 Shoulder Injury and Treatment Surgery 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Hospital Xeral Calde's research output changed?
Output in 2018–2022 was 84% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Lugo
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.